B lymphocyte-typing for prediction of clinical response to rituximab

por Brezinschek, Hans-Peter, Rainer, Franz, Brickmann, Kerstin, Graninger, Winfried B
Publicado 2012

A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

por Stradner, Martin H., Dejaco, Christian, Brickmann, Kerstin, Graninger, Winfried B., Brezinschek, Hans Peter
Publicado 2016

Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)

por Leeb, Burkhard F, Haindl, Pia M, Brezinschek, Hans-Peter, Mai, Harsono T H, Deutsch, Christoph, Rintelen, Bernhard
Publicado 2015

Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey

por Puchner, Rudolf, Brezinschek, Hans Peter, Fritz, Josef, Herold, Manfred, Mustak, Monika, Nothnagl, Thomas, Puchner, Stephan E, Studnicka-Benke, Andrea, Leeb, Burkhard F
Publicado 2015

The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project

por Leeb, Burkhard F., Böttcher, Elke, Brezinschek, Hans-Peter, Czerwenka, Christoph, Herold, Manfred, Hitzelhammer, Hans, Mayrhofer, Franz, Puchner, Rudolf, Rainer, Franz, Rintelen, Bernhard, Schirmer, Michael, Stuby, Ulrike, Bröll, Hans
Publicado 2009

The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients

por Yazdani-Biuki, Babak, Brickmann, Kerstin, Wohlfahrt, Klaus, Mueller, Thomas, März, Winfried, Renner, Wilfried, Gutjahr, Manuela, Langsenlehner, Uwe, Krippl, Peter, Wascher, Thomas C, Paulweber, Bernhard, Graninger, Winfried, Brezinschek, Hans-Peter
Publicado 2006